- Acasti Pharma Inc KOL Event TranscriptOct 11, 2023
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptOct 10, 2023
- Acasti Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) TranscriptMay 18, 2023
- Acasti Pharma Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q3 2023 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2023C$0.83 (-1.19%)Earnings
- Acasti Pharma Inc GTX-101 and GTX-102 Call TranscriptJan 10, 2023
- Q2 2023 Acasti Pharma Inc Earnings Call TranscriptNov 14, 2022C$0.63 (-3.08%)Earnings
- Q1 2023 Acasti Pharma Inc Earnings Call TranscriptAug 11, 2022C$1.15 (+3.60%)Earnings
- Q4 2022 Acasti Pharma Inc Earnings Call TranscriptJun 21, 2022C$1.22 (+0.83%)Earnings
- Acasti Pharma Inc Announces Positive Results for Pharmacokinetic Bridging Study Call TranscriptMay 18, 2022
- Acasti Pharma Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- Q3 2022 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2022C$1.58 (+4.64%)Earnings
- Q2 2022 Acasti Pharma Inc Earnings Call TranscriptNov 10, 2021C$2.06 (-1.90%)Earnings
- Acasti Pharma Inc Planned Acquisition of Grace Therapeutics Inc Call TranscriptAug 04, 2021
- Acasti Pharma Inc Annual Shareholders Meeting TranscriptSep 30, 2020
- Q4 2020 Acasti Pharma Inc Earnings Call TranscriptJun 29, 2020C$5.28 (-13.16%)Earnings
- Q3 2020 Acasti Pharma Inc Earnings Call TranscriptFeb 14, 2020C$6.08Earnings
- Q2 2020 Acasti Pharma Inc Earnings Call TranscriptNov 13, 2019C$21.76 (-4.23%)Earnings
- Q1 2020 Acasti Pharma Inc Earnings Call TranscriptAug 14, 2019C$21.76 (+7.09%)Earnings
- Q4 2019 Acasti Pharma Inc Earnings Call TranscriptJun 26, 2019C$12.24 (+7.75%)Earnings
Acasti Pharma Inc Planned Acquisition of Grace Therapeutics Inc Call Transcript
Good day, ladies and gentlemen, and welcome to the Acasti Pharma Business Update Conference Call. (Operator Instructions) At this time, it is my pleasure to turn the floor over to your host, David Waldman, Investor Relations. Sir, the floor is yours.
Thank you. Good afternoon, everyone, and welcome to this investor conference call to discuss Acasti's proposed acquisition of Grace Therapeutics. On the call with us from Acasti are Jan D' Alvise, President and CEO; Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; and Brian Ford, Chief Financial Officer. Also joining us from the Grace team are George Kottayil, Co-Founder and CEO; and Prashant Kohli, Vice President of Commercial Operations.
I'd also like to remind everyone that statements on this conference call that are not statements of historical or current fact constitute forward-looking information within the meaning of Canadian securities laws and forward looking statements within the meaning of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)